Labcorp Holdings Inc. (LON:0JSY)
253.09
-0.68 (-0.27%)
Dec 23, 2025, 5:00 PM BST
Labcorp Holdings Revenue
Labcorp Holdings had revenue of $3.56B USD in the quarter ending September 30, 2025, with 8.58% growth. This brings the company's revenue in the last twelve months to $13.77B, up 8.28% year-over-year. In the year 2024, Labcorp Holdings had annual revenue of $13.01B with 6.97% growth.
Revenue (ttm)
$13.77B
Revenue Growth
+8.28%
P/S Ratio
1.54
Revenue / Employee
$196.65K
Employees
70,000
Market Cap
15.72B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13.01B | 847.30M | 6.97% |
| Dec 31, 2023 | 12.16B | 297.70M | 2.51% |
| Dec 31, 2022 | 11.86B | -1.27B | -9.68% |
| Dec 31, 2021 | 13.14B | -842.40M | -6.03% |
| Dec 31, 2020 | 13.98B | 2.42B | 20.98% |
| Dec 31, 2019 | 11.55B | 221.40M | 1.95% |
| Dec 31, 2018 | 11.33B | 1.03B | 9.95% |
| Dec 31, 2017 | 10.31B | 755.10M | 7.90% |
| Dec 31, 2016 | 9.55B | 872.80M | 10.06% |
| Dec 31, 2015 | 8.68B | 2.67B | 44.39% |
| Dec 31, 2014 | 6.01B | 203.30M | 3.50% |
| Dec 31, 2013 | 5.81B | 136.90M | 2.41% |
| Dec 31, 2012 | 5.67B | 129.10M | 2.33% |
| Dec 31, 2011 | 5.54B | 538.40M | 10.76% |
| Dec 31, 2010 | 5.00B | 309.20M | 6.59% |
| Dec 31, 2009 | 4.69B | 189.50M | 4.21% |
| Dec 31, 2008 | 4.51B | 437.00M | 10.74% |
| Dec 31, 2007 | 4.07B | 477.40M | 13.30% |
| Dec 31, 2006 | 3.59B | 263.20M | 7.91% |
| Dec 31, 2005 | 3.33B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Genus | 672.80M |
| HUTCHMED (China) | 439.54M |
Labcorp Holdings News
- 8 days ago - Cofactor Genomics Announces Strategic Investment by Labcorp and Ascension Ventures to Fuel Expansion of Its OncoPrism® Immunotherapy Diagnostic Across U.S. Cancer Care Networks - Business Wire
- 20 days ago - Price Over Earnings Overview: Labcorp Hldgs - Benzinga
- 21 days ago - Community Health Systems Completes Sale of Select Outreach Laboratory Assets to Labcorp - Business Wire
- 21 days ago - Should You Continue to Hold LH Stock in Your Portfolio? - Nasdaq
- 21 days ago - Labcorp (LH) Stock Signal: Can the Rally Continue? - 02 December 2025 - DailyForex
- 4 weeks ago - LabCorp Holdings Inc. (LH) Files Form 8-K with SEC - GuruFocus
- 4 weeks ago - Ex-Dividend Reminder: PVH, Brunswick and Labcorp Holdings - Nasdaq
- 4 weeks ago - Labcorp Appoints Victor Bulto to Board of Directors - PRNewsWire